MRNS - Marinus Pharmaceuticals, Inc. Biznesning balans bahosi

Ommaviy kompaniya Marinus Pharmaceuticals, Inc. (MRNS) logotipi

Marinus Pharmaceuticals (MRNS) noyob antikonvulsant davolash vositalarini ishlab chiqishga ixtisoslashgan. Moliyaviy noaniqlik sezilarli qarzlar va dori vositalarini bozorga chiqarishdagi potentsial uzilishlar tufayli yuzaga kelmoqda. Hozirda rahbariyat xarajatlarni optimallashtirmoqda va asosiy mahsulotga e'tibor qaratish uchun ishlab chiqish dasturini qayta ko'rib chiqmoqda, shu bilan birga ko'rsatkich -0.07 darajasida turibdi. Ushbu grafikdagi narx harakati biznesning yuqori makro-barqarorligini namoyish etadi, u mavsumiy tebranishlar yoki bozor sikllaridan ta'sirlanmaydi.

MRNS Marinus Pharmaceuticals, Inc. Balans kapitallashuvi (04.07.2022 - 22.02.2025)

Marinus Pharmaceuticals, Inc. (MRNS) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Marinus Pharma|MRNS - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Marinus Pharmaceuticals Inc|MRNS - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Marinus Pharmaceuticals|MRNS - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti marinuspharma.com|MRNS - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Marinus Pharmaceuticals|MRNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Marinus Pharmaceuticals Inc|MRNS - Kompaniya qarzlari|Balans qiymatiga qarzlar Marinus Pharmaceuticals Inc|MRNS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Marinus Pharmaceuticals
Kompaniyaning jamlanma tahlili:Marinus Pharma - MRNS
Marinus Pharmaceuticals Inc yetakchi tovari

"Qiymat tuzog'i" xavflarini minimallashtirish uchun investorlar barcha majburiyatlar ayirilgandan keyingi sof aktivlarning haqiqiy o'sishini kuzatishlari kerak. Kompaniyaning kitob kapitalizatsiyasi tendentsiyasini tahlil qilish orqali Marinus Pharmaceuticals (MRNS) dagi kapital shakllanishi samaradorligini baholash mumkin, bu esa ganaxolone pipeline loyihasini kengaytirish va neyrofarmatsevtika sektorida bozor ulushini egallash uchun Ztalmy dori vositasini tijorat nuqtai nazaridan targ'ib qilishda juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

BIIB: Buxgalteriya kapitallashuvi|Neurocrine Biosciences - Kompaniyaning balans qiymati|RGC (regencellbioscience.com) - Biznesning balans bahosi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|AMLX (Amylyx Corp) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati TRVI|Kompaniyaning sof aktivlari praxismedicines.com|Balans kapitallashuvi AVXL|Balans kapitallashuvi CBLL (CeriBell Inc)|Kompaniyaning balans qiymati prothena.com|Kompaniyaning buxgalteriya qiymati Alector Inc. ALEC|Balans kapitallashuvi ANNX (Annexon, Inc.)|OMER: Biznesning balans bahosi|Kompaniyaning balans qiymati Neurogene|Buxgalteriya kapitallashuvi AC Immune S.A.|VYGR (Voyager Pharma) - Kompaniyaning sof aktivlari|Balans kapitallashuvi NMRA|SCLX (Scilex Holding Company) - Kompaniyaning balans qiymati|Biznesning balans bahosi tevogen.com TVGN|Kompaniyaning sof aktivlari Alpha Cognition Inc.|cogrx.com - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Inhibikase|SAVA - Sof aktivlar qiymati|Balans kapitallashuvi assertiotx.com ASRT|Coya Therapeutics (COYA) - Kompaniyaning buxgalteriya qiymati|VTGN (VistaGen Therapeutics, Inc.) - Balans kapitallashuvi|Balans kapitallashuvi OVID|Acumen Pharma (ABOS) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati CRVO (CervoMed Corporation)|Alterity Therapeutics Limited - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Clene Inc CLNN|PepGen Corp - Balans kapitallashuvi|JUNS - Balans kapitallashuvi|RLMD (Relmada) - Balans kapitallashuvi|Annovis Bio Corporation (ANVS) - Kompaniyaning sof aktivlari|Balans kapitallashuvi GRCE (Grace Therapeutics Inc)|Kompaniyaning xususiy kapitali fireflyneuro.com (AIFF)|Kompaniyaning sof aktivlari KLTO|Balans kapitallashuvi neurosense-tx.com NRSN|Kompaniyaning sof aktivlari Reviva Pharmaceuticals Holdings (RVPH)|Jami sof aktivlar MetaVia Inc. MTVA|Balans kapitallashuvi NRXS (NeurAxis, Inc.)|HSDT - Biznesning balans bahosi|PASG (passagebio.com) - Balans kapitallashuvi|Neuphoria Therapeutics (NEUP) - Kompaniyaning sof aktivlari|NERV (Minerva Neurosciences Corp) - Balans kapitallashuvi|Balans kapitallashuvi ATHA|Kompaniyaning balans qiymati Addex Therapeutics (ADXN)|Kompaniyaning balans qiymati ALZN (alzamend.com)|Kompaniyaning balans qiymati CYCN|Protagenic Therapeutics Inc. - Biznesning balans bahosi|KTTA: Kompaniyaning balans qiymati|CRGT: Kompaniyaning sof aktivlari|Kompaniyaning balans qiymati Avenue Therapeutics ATXI|BCLI (brainstorm-cell.com) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Cara Therapeutics (CARA)|Buxgalteriya kapitallashuvi CHRO|ELYM (Eliem Therapeutics) - Kompaniyaning balans qiymati|Biznesning balans bahosi ITCI (intracellulartherapies.com)|LBPH - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi nkgenbiotech.com NKGN|NRBO (NeuroBo Pharmaceuticals, Inc.) - Balans kapitallashuvi|Sage Therapeutics Inc. (SAGE) - Kompaniyaning xususiy kapitali|SNPX: Kompaniyaning sof aktivlari|TRVN (Trevena Inc) - Balans kapitallashuvi|VIGL - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati WENA|Cerevel Therapeutics, Inc. - Kompaniyaning balans qiymati